Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) poses a significant global health concern, with its incidence steadily increasing. The development of HCC is a multifaceted, multi-step process involving alterations in various signaling cascades. In recent years, significant progress has been made in understanding the...
Saved in:
Main Authors: | Jieun Bang (Author), Mihyeon Jun (Author), Soyun Lee (Author), Hyuk Moon (Author), Simon Weonsang Ro (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tenacissoside H Induces Autophagy and Radiosensitivity of Hepatocellular Carcinoma Cells by PI3K/Akt/mTOR Signaling Pathway
by: Jiatian Lin, et al.
Published: (2021) -
MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
by: Zhenyu Zhang, et al.
Published: (2018) -
The Exosome-Mediated PI3K/Akt/mTOR Signaling Pathway in Neurological Diseases
by: Amin Iranpanah, et al.
Published: (2023) -
PI3K/AKT/mTOR Signaling Pathway Is Downregulated by Runzaoling (RZL) in Sjögren's Syndrome
by: Ping Zeng, et al.
Published: (2022) -
Targeting PI3K/mTOR signaling in cancer
by: Alexandre Arcaro
Published: (2014)